Washington, July 22 -- Representative Mike Quigley issued the following press release:
On Wednesday, the House of Representatives voted on and passed the Access to Critical Therapies for ALS Reauthorization Act (ACT for ALS Reauthorization Act) of 2026 with bipartisan support. Led by Representatives Mike Quigley (IL-05) and Ken Calvert (CA-41), the ACT for ALS Reauthorization Act will further advance the scientific understanding of neurodegenerative diseases and help people living with ALS continue to access promising treatments. The bill previously passed through the Energy and Commerce Committee in May with zero 'No' votes.
"Over the past five years, the programs created by the ACT for ALS have helped thousands of people living with ALS...